Join Patrick Georgoff as he welcomes Dr. Gene Moore and Dr. Ian Roberts, two giants in trauma surgery and epidemiology, to discuss tranexamic acid (TXA) in trauma care. Dr. Moore, a legendary trauma surgeon and researcher, and Dr. Roberts, the architect of the CRASH trials, break down the science, controversies, and practical applications of TXA. They explore who should get TXA, when it should be given, optimal dosing, and its potential risks. With insights from landmark trials like CRASH-2, STAMP, PATCH, and ROC TXA, this episode cuts through the confusion surrounding TXA in trauma and traumatic brain injury. Is early administration the key to saving lives? Should TXA be given intramuscularly prehospital? Tune in as we tackle these critical questions and define the future of TXA in trauma care! This episode of Big T Trauma was sponsored by Teleflex, a global provider of medical devices. Learn more at teleflex.com and at the Teleflex Trauma and Emergency Medicine LinkedIn page. ***Fellowship Application Link: https://forms.gle/PQgAvGjHrYUqAqTJ9 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen BIG T Trauma Series: https://app.behindtheknife.org/podcast-series/big-t-trauma

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related